KRT18 and breast cancer: Based on a retrospective multi-marker study including patients with primary and recurrent BC, the quantitative POC assay UBC® Rapid assay targeting cytokeratin 18 and 20, showed a sensitivity of 46.4% and a specificity of 75% for low grade BC, and 70.5% and 75.5% for high-grade BC, respectively.